Short answer: This article explains the key facts, eligibility issues, settlement factors, deadlines, and source-backed updates related to this legal topic. Results vary by case facts, evidence, jurisdiction, and representation.
In brief: The Depo Provera brain tumor lawsuit centers on allegations that years of injections of medroxyprogesterone acetate, the drug sold as Depo-Provera, raise the risk of an intracranial meningioma, and that patients never received an adequate warning.
Below, Legal Lawsuit walks through who qualifies, the medical proof that matters, what drives settlement value, filing deadlines, where the litigation stands and how to get a free, confidential case review.
Depo-Provera Meningioma Lawsuit Explained
This Depo Provera brain tumor lawsuit is a mass tort brought by people who say a meningioma formed after they received Depo-Provera shots. Their core claim is that the drugmaker did not adequately warn about the meningioma risk linked to repeated or long-term injections.
In federal court, the cases are consolidated as In re: Depo-Provera (Medroxyprogesterone Acetate) Products Liability Litigation, MDL No. 3140, before Judge M. Casey Rodgers in the Northern District of Florida. The court's MDL page confirms the proceeding and its transfer there for coordinated pretrial handling.
A meningioma grows from the protective layers covering the brain and spinal cord. Many are labeled benign, but they can still bring seizures, headaches, vision loss, neurological and memory problems, brain surgery, radiation, years of scans for regrowth and lasting changes to daily life.
The Science: Depo-Provera and Meningioma Risk
The science behind the Depo Provera brain tumor lawsuit comes largely from studies of progestogens and meningioma. A 2024 study in The BMJ linked prolonged use of injected medroxyprogesterone acetate to a higher risk of intracranial meningioma, and the BMJ Group's summary put the increase at 5.6 times for long-term injection users.
The active ingredient in Depo-Provera, medroxyprogesterone acetate, is a lab-made progestin. Because many meningiomas carry hormone receptors, plaintiffs commonly argue that years of hormone exposure can fuel tumor growth in people who are susceptible.
Depo-Provera's FDA-approved label now has a meningioma warning noting reported cases after repeated doses of medroxyprogesterone acetate, mostly with long-term use. That wording matters to patients and to attorneys examining when and how the warning changed.
Depo-Provera Brain Tumor Lawsuit Settlement Amounts 2026
No guaranteed settlement amount exists for any depo provera brain tumor lawsuit claim. Settlement projections are educational only because actual value depends on diagnosis severity, surgery, radiation, treatment duration, proof of Depo-Provera use, warnings issues, jurisdiction, deadline risk, medical causation, and expert review.
| Severity Tier | Injury Profile | Educational Range |
|---|---|---|
| Tier 1 — Severe | Brain surgery, recurrence, permanent neurological impairment, long-term care, or major disability | $350,000–$600,000+ |
| Tier 2 — Significant | Surgery required, extended recovery, vision issues, seizures, or lasting neurological symptoms | $175,000–$350,000 |
| Tier 3 — Moderate | Radiation, monitoring, documented tumor, limited lasting effects, and clear use history | $75,000–$175,000 |
| Tier 4 — Baseline Review | Confirmed meningioma, watchful waiting, documented Depo-Provera use, and deadline review needed | $25,000–$75,000 |
Who Qualifies for a Depo Provera Brain Tumor Lawsuit?
Whether you qualify for a Depo Provera brain tumor lawsuit typically turns on your diagnosis, how long you received the shot, the records you have, timing and your state's deadline rules.
Potentially stronger claims
- A meningioma in the brain or skull diagnosed after receiving Depo-Provera shots.
- Repeated or long-term injectable medroxyprogesterone acetate use.
- Records from MRIs, pathology, surgery, radiation, neurology or oncology care.
- Proof of injections such as pharmacy fills, OB/GYN logs or prescription records.
- Serious symptoms, an operation, lasting impairment, missed income or large medical bills.
Claims needing closer review
- Spinal-only meningioma or uncertain tumor type.
- Short-term use or unclear injection history.
- Missing medical records or pharmacy documentation.
- Diagnosis before Depo-Provera use began.
- Expired or uncertain state filing deadline.
Pfizer Liability and the Failure-to-Warn Theory
Most Depo Provera brain tumor lawsuit claims rest on a failure-to-warn theory: that the drugmaker knew, or should have known, about the meningioma risk and did not adequately tell patients or their doctors.
The defense can push back in several ways, such as challenging the science on causation, invoking federal labeling law and FDA communications, pointing to other possible causes in a given case, or arguing a different warning would not have changed the prescribing decision. News coverage has reported that Pfizer is pressing a federal preemption defense.
Since the warning and causation issues are complicated, each claim needs a close look at the injection history, when the label changed, medical and prescribing records and the governing state law.
Steps to File a Depo-Provera Meningioma Claim
A Depo Provera brain tumor lawsuit begins with gathering records and having an attorney review them. Attorneys handling these cases usually review them free of charge on a contingency basis, so there is no attorney fee unless money is recovered.
1. Gather Depo-Provera records
Pull together injection and pharmacy records, OB/GYN notes, prescription history and anything showing when and how long you received the shot.
2. Gather tumor records
Gather MRI and pathology reports, surgical and radiation records, neurology and oncology notes, plus a timeline of your symptoms.
3. Request legal review
An experienced attorney can evaluate causation, your injection history, injuries, damages, deadline risks and whether the claim fits the litigation's criteria.
Filing Deadlines by State
Ask about your deadline now. The time limit for a Depo Provera brain tumor lawsuit differs from state to state and can hinge on when you were diagnosed, when you learned of the Depo-Provera link, the warnings, the injury date and other rules.
| State Example | Common Personal Injury/Product Liability Period | Deadline Note |
|---|---|---|
| California | Often 2 years | Discovery-rule issues may apply. |
| Florida | Often 2 years for negligence-based injury claims | Product and discovery rules require attorney review. |
| New York | Often 3 years | Depends on the type of claim and when the injury was discovered. |
| Texas | Often 2 years | Strict timing review is important. |
| Illinois | Often 2 years | Discovery and repose rules may matter. |
Depo Provera Brain Tumor Lawsuit Updates 2026
The federal litigation is active in MDL No. 3140 in the Northern District of Florida. The official court page identifies the MDL and the assigned judge. Because MDL schedules, case counts, motions, and bellwether timelines can change quickly, users should rely on official court materials and attorney review for the latest procedural status.
Sources and External References
The references below back up the regulatory, scientific, legal and medical points made on this page. They're listed for transparency and citation, not as legal or medical advice.
- U.S. District Court, N.D. Florida: MDL No. 3140 (Depo-Provera product liability). Accessed June 10, 2026.
- FDA: Depo-Provera CI prescribing label with meningioma warning. Accessed June 10, 2026.
- The BMJ: progestogen use and intracranial meningioma risk study. Accessed June 10, 2026.
- BMJ Group press summary: long-term hormone drug use and brain tumour risk. Accessed June 10, 2026.
- NCI: Meningioma treatment overview (PDQ, patient version). Accessed June 10, 2026.
- AANS patient guide to meningiomas. Accessed June 10, 2026.
- Google Search Central: guidance on helpful, people-first content. Accessed June 10, 2026.
- Google Search Central: structured data policies. Accessed June 10, 2026.
Depo Provera Brain Tumor Lawsuit: Common Questions
What is the Depo-Provera meningioma lawsuit about?
These cases allege that Depo-Provera shots are linked to meningioma and that neither patients nor doctors were properly warned of the risk.
What is a Depo-Provera brain tumor claim worth?
There is no guaranteed value. Educational ranges may vary from lower five figures to higher six figures depending on diagnosis, surgery, disability, records, and attorney review.
Who may qualify?
Anyone diagnosed with an intracranial meningioma after repeated or long-term Depo-Provera shots may be a candidate for review, particularly with solid medical and injection records.
Do I need surgery to qualify?
No. Surgery can make a case more serious, but a confirmed diagnosis with radiation, ongoing monitoring or significant symptoms can still be worth having reviewed.
Is there a filing deadline?
Yes. Each state sets its own time limit, which can depend on the diagnosis date, when the link was discovered, the warnings and other facts, so get a prompt review.
Does this page give legal advice?
No. Legal Lawsuit provides educational information only, and reading this page does not make you anyone's client.
Request a Free Depo-Provera Meningioma Case Review
Received Depo-Provera shots and later learned you have a meningioma? Call for a free, confidential review to see whether your records could support a claim, with no up-front cost.
Related Posts
Quick Answer: The Boy Scouts of America (BSA) filed for Chapter 11 bankruptcy in 2020 after facing tens of thousands [...]
Quick Answer: Survivors of sexual abuse by Catholic priests, nuns, or other Church personnel may be able to file a [...]
Quick Answer: Clergy abuse settlements vary enormously based on the severity of the abuse, the strength of evidence that the [...]
